Nestod Adalvo (Desmopressin Acetate)

Desmopressin Acetate, the active ingredient in Nestod Adalvo, is a vasopressin analog presented as an oral tablet for oral use. It treats central diabetes insipidus, nocturnal enuresis, and primary nocturnal polyuria in appropriate patients.

GNH USA supplies Nestod Adalvo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin acetate is used to manage disorders of water balance that involve deficient antidiuretic hormone activity. - Central diabetes insipidus: reduces excessive urine output by increasing water reabsorption. - Nocturnal enuresis: decreases nighttime bedwetting episodes in children and adolescents. - Primary nocturnal polyuria: lowers nighttime urine volume in adults with overproduction.

Desmopressin acetate may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate pain in the head. - Nausea: upset stomach or urge to vomit. - Hyponatremia: low blood sodium, usually mild. - Flushing: transient redness of the skin.

Serious or Rare Side Effects: - Severe hyponatremia: marked low sodium that can lead to seizures or coma. - Water intoxication: excessive water retention causing edema. - Allergic reaction: rash, itching, or swelling.

Before prescribing Nestod Adalvo, clinicians should consider several safety measures. - Assess sodium: monitor serum sodium before and during therapy. - Adjust dose in renal impairment: reduce dose in patients with reduced kidney function. - Avoid excess fluid intake: counsel patients to limit fluid consumption to prevent hyponatremia. - Use caution in elderly: increased risk of water retention and hyponatremia. - Pregnancy category B: consider use only when benefit outweighs potential risk. - Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

Desmopressin acetate can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Carbamazepine: may reduce desmopressin efficacy. - Thiazide diuretics: increase risk of hyponatremia. - NSAIDs (e.g., ibuprofen): can potentiate antidiuretic effect and hyponatremia.

Moderate Interactions (Monitor Closely): - Antihypertensives: may enhance hypotensive effect. - Other antidiuretic agents: monitor fluid balance closely. - Estrogen therapy: may increase desmopressin plasma levels.